21.1 A 65nm CMOS Living-Cell Dynamic Fluorescence Sensor with 1.05fA Sensitivity at 600/700nm Wavelengths

2023 IEEE International Solid-State Circuits Conference (ISSCC)(2023)

引用 0|浏览3
暂无评分
摘要
Integrated, low-cost and miniaturized devices that can detect clinically relevant biomarkers are crucial for the growing field of precision medicine as they can enable point-of-care diagnosis, continuous health monitoring and closed-loop drug delivery. Fluorescence (FL) sensing is known to be one of the most reliable, sensitive, and widely adopted sensing modality for many biomarkers [1], [3]. However, detecting the weak FL signal requires complex optical setups, especially narrowband optical filters to block the strong excitation (EX) light. Prior efforts [1] to miniaturize and implement FL sensing in CMOS technologies have been limited to on-chip high-pass filters using dense vertical waveguide arrays. More importantly, the reported wavelength range of 800nm in [1] is not compatible with most of the commonly used fluorescent proteins that work with living cells [4]. Luminescence is another mechanism for detecting biomarkers that does not require an EX source and optical filtering [2]. However, there are limited number of luminescence proteins, and it is not feasible to use them in a closed-loop system since they can interfere with optogenetic control integration [5].
更多
查看译文
关键词
clinically relevant biomarkers,closed-loop drug delivery,closed-loop system,CMOS living-cell dynamic fluorescence sensor,CMOS technologies,complex optical setups,continuous health monitoring,current 1.05 fA,dense vertical waveguide arrays,excitation light,fluorescence sensing,fluorescent proteins,miniaturized devices,narrowband optical filters,on-chip high-pass filters,optical filtering,point-of-care diagnosis,precision medicine,ptogenetic control integration,reported wavelength range,sensing modality,size 65.0 nm,wavelength 600.0 nm,wavelength 700.0 nm,weak FL signal
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要